Figure 7
From: Bradykinin inhibits hepatic gluconeogenesis in obese mice
Effect of bradykinin (BK) in cultured hepatome cells (FAO). The cells were distributed in two groups: with or without fetal bovine serum (+FBS or −FBS). Three different conditions were used concerning absence or addition of insulin and cAMP. Each condition was tested with or without BK (10−6 M) and HOE140 (10−6 M), a BKB2R antagonist. Values are presented as mean±s.e.m., *P<0.05, n=3.
